| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Sep―23 |
Trends in cognitive impairment among older adults in China from 2002 to 2022: Evaluating the impact of the COVID-19 pandemic |
Lei Feng, Kaisy Xinhong Ye, Qiushi Feng, Yan Mo, Zuqi Cai, Chunbo Li, Jintai Yu, Bin Li, Andrea B. Maier, Yi Zeng, Zhenglian Wang |
| 2 |
[GO] |
2024―Jul―31 |
Effects of the COVID-19 Pandemic on the Number of New Dementia Diagnoses and the Quality of Dementia Diagnostics and Treatment |
M.T. Hoang, P.G. Jurado, T. Abzhandadze, S. Mostafaei, M. Mo, M. Åkerman, K. Vestling, C. Chen, H. Xu, M. Eriksdotter, S. Garcia-Ptacek |
| 3 |
[GO] |
2022―Sep―16 |
Alzheimer’s Disease Clinical Trial Research Adaptation Following COVID-19 Pandemic Onset: National Sample of Alzheimer’s Clinical Trial Consortium Sites |
E.K. Rhodus, P. Aisen, J.D. Grill, D.M. Rentz, R.C. Petersen, R.A. Sperling, S.P. Salloway, D. Pierce, R. Raman |
| 4 |
[GO] |
2021―Jun―24 |
Using Digital Tools to Advance Alzheimer’s Drug Trials During a Pandemic: The EU/US CTAD Task Force |
J. Kaye, R. Amariglio, R. Au, C. Ballard, M. Carrillo, H. Fillit, T. Iwatsubo, G. Jimenez-Maggiora, S. Lovestone, F. Natanegara, K. Papp, M.E. Soto, M. Weiner, P. Aisen |
| 5 |
[GO] |
2021―Feb―25 |
IMPACT OF THE COVID-19 OUTBREAK ON THE CLINICAL AND RESEARCH ACTIVITIES OF MEMORY CLINICS: AN ALZHEIMER’S DISEASE CENTER FACING THE COVID-19 CRISIS |
P.J. Ousset, B. Vellas |
| 6 |
[GO] |
2021―Feb―25 |
TOULOUSE ALZHEIMER’S CLINICAL RESEARCH CENTER RECOVERY AFTER THE COVID-19 CRISIS: TELEMEDICINE AN INNOVATIVE SOLUTION FOR CLINICAL RESEARCH DURING THE CORONAVIRUS PANDEMIC |
C. Takeda, S. Guyonnet, P.J. Ousset, M. Soto, B. Vellas |
| 7 |
[GO] |
2021―Feb―25 |
THE SARS-COV-2 PANDEMIC AND THE BRAVE NEW DIGITAL WORLD OF ENVIRONMENTAL ENRICHMENT TO PREVENT BRAIN AGING AND COGNITIVE DECLINE |
H. Hampel, A. Vergallo |
|
